- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 3 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: S.691, A.693, N.1061
- Chain C: Q.882
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 1 residues within 4Å:- Chain A: N.1121
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 6 residues within 4Å:- Chain A: N.704, F.705, T.706, L.909, Q.913, Q.1058
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 2 residues within 4Å:- Chain A: N.788, S.790
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 4 residues within 4Å:- Chain A: N.1085, T.1087, H.1088, F.1090
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 3 residues within 4Å:- Chain A: K.545
- Chain C: E.268, N.269
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 1 residues within 4Å:- Chain C: N.1121
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 4 residues within 4Å:- Chain C: N.1085, T.1087, H.1088, F.1090
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 1 residues within 4Å:- Chain D: N.1121
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 4 residues within 4Å:- Chain D: N.704, L.909, N.912, Q.1058
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.912
NAG-NAG.14: 2 residues within 4Å:- Chain D: N.788, S.790
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 4 residues within 4Å:- Chain D: N.1085, T.1087, H.1088, F.1090
No protein-ligand interaction detected (PLIP)- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 1 residues within 4Å:- Chain A: N.330
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: N.318, Q.567
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: N.696, G.1118
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain C: N.330
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain C: Y.15, F.46, N.48
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain C: N.318
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain C: N.590
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain C: N.603, T.605
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain C: N.644
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain C: N.696
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain C: N.704, Q.913, Q.1058
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain C: N.788, S.790, Q.791
Ligand excluded by PLIPNAG.28: 7 residues within 4Å:- Chain D: F.325, G.326, E.327, V.328, F.329, N.330, L.355
Ligand excluded by PLIPNAG.29: 6 residues within 4Å:- Chain D: Q.1, C.2, N.4, C.123, N.124, D.125
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain D: N.48
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain D: N.318
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain A: D.783
- Chain D: N.696, G.1118
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain A: Q.882
- Chain D: N.1061
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, Z. et al., A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants. Signal Transduct Target Ther (2021)
- Release Date
- 2021-11-24
- Peptides
- Spike glycoprotein: ACD
n3113: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CC
AD
BB
V
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-mer
- Ligands
- 3 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, Z. et al., A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants. Signal Transduct Target Ther (2021)
- Release Date
- 2021-11-24
- Peptides
- Spike glycoprotein: ACD
n3113: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CC
AD
BB
V